AstraZeneca resolves Faslodex patent litigation in U.S.

The U.S. Faslodex patents are due to expire in January 2021, with paediatric exclusivity continuing until July 2021.

(Reporting by Rahul B in Bengaluru- Editing by Sunil Nair)